ArticleHepatology (Baltimore, Md.)2018

Src kinase inhibition reduces inflammatory and cytoskeletal changes in ΔF508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy.

Romina Fiorotto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.